Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1-O-hexadecyl-sn-glycero-3-phosphocholine + acetyl-CoA
1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine + CoA
acetyl-CoA + 1-acyl-sn-glycero-3-phosphate
CoA + 2-acetyl-1-acyl-sn-glycero-3-phosphate
-
Substrates: -
Products: -
?
acetyl-CoA + 1-acyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-acyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
acetyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
acetyl-CoA + 1-hexadecyl-2-lyso-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-hexadecyl-sn-glycero-3-phosphocholine
acetyl-CoA + 1-O-alkyl-sn-glycero-3-phosphate
CoA + 2-acetyl-1-alkyl-6-phosphate
-
Substrates: -
Products: -
?
acetyl-CoA + 1-O-alkyl-sn-glycero-3-phosphocholine
?
-
Substrates: -
Products: -
?
acetyl-CoA + 1-O-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-6-phosphocholine
acetyl-CoA + 1-octadecyl-2-lyso-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-octadecyl-sn-glycero-3-phosphocholine
acetyl-CoA + 1-palmitoyl-2-lyso-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-palmitoyl-sn-glycero-3-phosphocholine
acetyl-CoA + acetyl-phosphatidylcholine
?
-
Substrates: -
Products: -
?
acetyl-CoA + acyl-lyso-glycero-3-phosphocholine
CoA + acetyl-acyl-glycero-3-phosphocholine
acetyl-CoA + alk-1-enyl-lyso-glycero-3-phosphoethanolamine
CoA + acetyl-alk-1-enyl-glycero-3-phosphoethanolamine
acetyl-CoA + alkyl-lyso-glycero-3-phosphoethanolamine
CoA + 2-acetyl-alkyl-glycero-3-phosphoethanolamine
acetyl-CoA + alkyl-lyso-monomethylethanamine
?
acetyl-CoA + alkyl-lyso-N',N'-dimethylethanamine
?
acetyl-CoA + alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
acetyl-CoA + hexadecyl-lyso-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-hexadecyl-sn-glycero-3-phosphocholine
acetyl-CoA + lyso-phosphatidylcholine
CoA + 2-acetyl-1-acylphosphatidylcholine
-
Substrates: -
Products: -
?
acetyl-CoA + lyso-phosphatidylethanolamine
CoA + 2-acetyl-1-acyl-phosphatidylethanolamine
-
Substrates: -
Products: -
?
acetyl-CoA + lyso-platelet activating factor
CoA + platelet activating factor
-
Substrates: -
Products: -
?
acetyl-CoA + lyso-platelet-activating factor
?
-
Substrates: -
Products: -
?
acetyl-CoA + lyso-platelet-activating factor
platelet-activating factor + CoA
acetyl-CoA + octadecyl-lyso-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-octadecyl-sn-glycero-3-phosphocholine
acetyl-CoA + phosphatidylcholine
?
-
Substrates: -
Products: -
?
butyryl-CoA + 1-alkyl-2-lyso-sn-glycero-3-phosphocholine
2-butyryl-1-alkyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
hexanoyl-CoA + 1-alkyl-2-lyso-sn-glycero-3-phosphocholine
2-hexanoyl-1-alkyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
lyso-platelt activating factor + acetyl-CoA
?
-
Substrates: -
Products: -
?
oleoyl-CoA + alkyl-lyso-glycero-3-phosphoethanolamine
CoA + 1-alkyl-2-oleoyl-glycero-3-phosphoethanolamine
-
Substrates: 10% of the activity observed in presence of acetyl-CoA
Products: -
?
palmitoyl-CoA + alkyl-lyso-glycero-3-phosphoethanolamine
CoA + acetyl-2-palmitoyl-glycero-3-phosphoethanolamine
-
Substrates: 5% of the activity observed in presence of acetyl-CoA
Products: -
?
propionyl-CoA + alkyl-lyso-glycero-phosphocholine
CoA + 2-propionyl-1-alkyl-sn-glycero-3-phosphocholine
additional information
?
-
1-O-hexadecyl-sn-glycero-3-phosphocholine + acetyl-CoA
1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine + CoA
-
Substrates: lyso-PAF, lyso-platelet-activating factor
Products: PAF, platelet-activating factor
?
1-O-hexadecyl-sn-glycero-3-phosphocholine + acetyl-CoA
1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine + CoA
Substrates: lyso-PAF, lyso-platelet-activating factor
Products: PAF, platelet-activating factor
?
acetyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
acetyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
Substrates: -
Products: -
?
acetyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
Substrates: substrates are d31-16:0 LPC or d4-lyso-PAF
Products: -
?
acetyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
Substrates: -
Products: -
?
acetyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
acetyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
Substrates: substrates are d31-16:0 LPC or d4-lyso-PAF
Products: -
?
acetyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
Substrates: -
Products: -
?
acetyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
acetyl-CoA + 1-hexadecyl-2-lyso-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-hexadecyl-sn-glycero-3-phosphocholine
-
Substrates: 40% higher activity respect to the C18 analogue
Products: -
?
acetyl-CoA + 1-hexadecyl-2-lyso-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-hexadecyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
acetyl-CoA + 1-O-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-6-phosphocholine
-
Substrates: final step in remodelling pathway of PAF biosynthesis
Products: -
?
acetyl-CoA + 1-O-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-6-phosphocholine
-
Substrates: -
Products: -
?
acetyl-CoA + 1-octadecyl-2-lyso-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-octadecyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
acetyl-CoA + 1-octadecyl-2-lyso-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-octadecyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
acetyl-CoA + 1-palmitoyl-2-lyso-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-palmitoyl-sn-glycero-3-phosphocholine
-
Substrates: rate reduced to 50%
Products: -
?
acetyl-CoA + 1-palmitoyl-2-lyso-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-palmitoyl-sn-glycero-3-phosphocholine
-
Substrates: 12% of the activity observed in presence of alkyl-lyso-sn-glycero-phosphocholine
Products: -
?
acetyl-CoA + 1-palmitoyl-2-lyso-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-palmitoyl-sn-glycero-3-phosphocholine
-
Substrates: rate of synthesis is 55% of the rate observed with the ether linked substrate
Products: -
?
acetyl-CoA + acyl-lyso-glycero-3-phosphocholine
CoA + acetyl-acyl-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
acetyl-CoA + acyl-lyso-glycero-3-phosphocholine
CoA + acetyl-acyl-glycero-3-phosphocholine
-
Substrates: worse substrate than alkyl-lyso-glycero-3-phosphocholine
Products: -
?
acetyl-CoA + alk-1-enyl-lyso-glycero-3-phosphoethanolamine
CoA + acetyl-alk-1-enyl-glycero-3-phosphoethanolamine
-
Substrates: -
Products: -
?
acetyl-CoA + alk-1-enyl-lyso-glycero-3-phosphoethanolamine
CoA + acetyl-alk-1-enyl-glycero-3-phosphoethanolamine
-
Substrates: -
Products: -
?
acetyl-CoA + alkyl-lyso-glycero-3-phosphoethanolamine
CoA + 2-acetyl-alkyl-glycero-3-phosphoethanolamine
-
Substrates: -
Products: -
?
acetyl-CoA + alkyl-lyso-glycero-3-phosphoethanolamine
CoA + 2-acetyl-alkyl-glycero-3-phosphoethanolamine
-
Substrates: least enzyme activity
Products: -
?
acetyl-CoA + alkyl-lyso-monomethylethanamine
?
-
Substrates: -
Products: -
?
acetyl-CoA + alkyl-lyso-monomethylethanamine
?
-
Substrates: -
Products: -
?
acetyl-CoA + alkyl-lyso-N',N'-dimethylethanamine
?
-
Substrates: -
Products: -
?
acetyl-CoA + alkyl-lyso-N',N'-dimethylethanamine
?
-
Substrates: -
Products: -
?
acetyl-CoA + alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
acetyl-CoA + alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
-
Substrates: alkyl-lyso-sn-glycero-3-phosphocholine is preferred to its saturated counterpart as substrate
Products: -
?
acetyl-CoA + alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
acetyl-CoA + alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
acetyl-CoA + alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
-
Substrates: the higher the degree of methylation of the nitrogen base, the lower the enzyme activity
Products: -
?
acetyl-CoA + alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
-
Substrates: the longer the acyl-CoA length, the smaller the values of apparent Km and Vmax
Products: -
?
acetyl-CoA + alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
-
Substrates: alkyl-lyso-sn-glycero-3-phosphocholine is preferred to its saturated counterpart as substrate
Products: -
?
acetyl-CoA + hexadecyl-lyso-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-hexadecyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
acetyl-CoA + hexadecyl-lyso-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-hexadecyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
acetyl-CoA + lyso-platelet-activating factor
platelet-activating factor + CoA
-
Substrates: -
Products: -
?
acetyl-CoA + lyso-platelet-activating factor
platelet-activating factor + CoA
Substrates: -
Products: -
?
acetyl-CoA + lyso-platelet-activating factor
platelet-activating factor + CoA
Substrates: intracellular redox state involved in regulating synthesis of platelet-activating factor (PAF)
Products: -
?
acetyl-CoA + lyso-platelet-activating factor
platelet-activating factor + CoA
Substrates: -
Products: -
?
acetyl-CoA + lyso-platelet-activating factor
platelet-activating factor + CoA
Substrates: -
Products: -
?
acetyl-CoA + lyso-platelet-activating factor
platelet-activating factor + CoA
Substrates: metabolic processing of platelet-activating factor (PAF) in naive and experimental allergic encephalomyelitis (EAE) mice
Products: -
?
acetyl-CoA + octadecyl-lyso-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-octadecyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
acetyl-CoA + octadecyl-lyso-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-octadecyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
acetyl-CoA + octadecyl-lyso-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-octadecyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
propionyl-CoA + alkyl-lyso-glycero-phosphocholine
CoA + 2-propionyl-1-alkyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
propionyl-CoA + alkyl-lyso-glycero-phosphocholine
CoA + 2-propionyl-1-alkyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
additional information
?
-
Substrates: enzyme is induced by bacterial endotoxin. The enzyme catalyzes not only biosynthesis of PAF from lyso-PAF but also incorporation of arachidonoyl-CoA to produce PAF precursor membrane glycerophospholipids (lysophosphatidylcholine acyltransferase activity). Under resting conditions, the enzyme prefers arachidonoyl-CoA and contributes to membrane biogenesis. Upon acute inflammatory stimulation with lipopolysaccharide, the activated enzyme utilizes acetyl-CoA more efficiently and produces PAF
Products: -
?
additional information
?
-
-
Substrates: the enzyme is activated 1. by a second-order time course after stimulation with platelet-activating factor receptor, 2. by a minute-order time course after LPS stimulation in the MyD88-dependent and p38 MAPK-dependent pathway, and 3. by an hour-order time course after LPS-stimulation in the MyD88-independent and TRIF-independent pathway
Products: -
?
additional information
?
-
Substrates: enzyme is induced by bacterial endotoxin. The enzyme catalyzes not only biosynthesis of PAF from lyso-PAF but also incorporation of arachidonoyl-CoA to produce PAF precursor membrane glycerophospholipids (lysophosphatidylcholine acyltransferase activity). Under resting conditions, the enzyme prefers arachidonoyl-CoA and contributes to membrane biogenesis. Upon acute inflammatory stimulation with lipopolysaccharide, the activated enzyme utilizes acetyl-CoA more efficiently and produces PAF
Products: -
?
additional information
?
-
Substrates: LPCAT1 recognizes a wide range of acyl-CoAs as substrates, ranging from acetyl-CoA to palmitoyl-CoA
Products: -
?
additional information
?
-
-
Substrates: LPCAT1 recognizes a wide range of acyl-CoAs as substrates, ranging from acetyl-CoA to palmitoyl-CoA
Products: -
?
additional information
?
-
Substrates: LPCAT2 also possesses lysophosphatidylcholine acyltransferase, EC: 2.3.1.23, activity that catalyzes the incorporation of arachidonoyl-CoA into membrane phosphatidylcholine
Products: -
?
additional information
?
-
-
Substrates: LPCAT2 also possesses lysophosphatidylcholine acyltransferase, EC: 2.3.1.23, activity that catalyzes the incorporation of arachidonoyl-CoA into membrane phosphatidylcholine
Products: -
?
additional information
?
-
Substrates: LPCAT2 also possesses lysophosphatidylcholine acyltransferase, EC: 2.3.1.23, activity that catalyzes the incorporation of arachidonoyl-CoA into membrane phosphatidylcholine
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1-O-hexadecyl-sn-glycero-3-phosphocholine + acetyl-CoA
1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine + CoA
acetyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
acetyl-CoA + 1-O-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-6-phosphocholine
-
Substrates: final step in remodelling pathway of PAF biosynthesis
Products: -
?
acetyl-CoA + lyso-platelet activating factor
CoA + platelet activating factor
-
Substrates: -
Products: -
?
acetyl-CoA + lyso-platelet-activating factor
?
-
Substrates: -
Products: -
?
acetyl-CoA + lyso-platelet-activating factor
platelet-activating factor + CoA
additional information
?
-
1-O-hexadecyl-sn-glycero-3-phosphocholine + acetyl-CoA
1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine + CoA
-
Substrates: lyso-PAF, lyso-platelet-activating factor
Products: PAF, platelet-activating factor
?
1-O-hexadecyl-sn-glycero-3-phosphocholine + acetyl-CoA
1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine + CoA
Substrates: lyso-PAF, lyso-platelet-activating factor
Products: PAF, platelet-activating factor
?
acetyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
acetyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
Substrates: -
Products: -
?
acetyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
Substrates: -
Products: -
?
acetyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
-
Substrates: -
Products: -
?
acetyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine
CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
Substrates: -
Products: -
?
acetyl-CoA + lyso-platelet-activating factor
platelet-activating factor + CoA
Substrates: -
Products: -
?
acetyl-CoA + lyso-platelet-activating factor
platelet-activating factor + CoA
Substrates: -
Products: -
?
additional information
?
-
Substrates: enzyme is induced by bacterial endotoxin. The enzyme catalyzes not only biosynthesis of PAF from lyso-PAF but also incorporation of arachidonoyl-CoA to produce PAF precursor membrane glycerophospholipids (lysophosphatidylcholine acyltransferase activity). Under resting conditions, the enzyme prefers arachidonoyl-CoA and contributes to membrane biogenesis. Upon acute inflammatory stimulation with lipopolysaccharide, the activated enzyme utilizes acetyl-CoA more efficiently and produces PAF
Products: -
?
additional information
?
-
-
Substrates: the enzyme is activated 1. by a second-order time course after stimulation with platelet-activating factor receptor, 2. by a minute-order time course after LPS stimulation in the MyD88-dependent and p38 MAPK-dependent pathway, and 3. by an hour-order time course after LPS-stimulation in the MyD88-independent and TRIF-independent pathway
Products: -
?
additional information
?
-
Substrates: enzyme is induced by bacterial endotoxin. The enzyme catalyzes not only biosynthesis of PAF from lyso-PAF but also incorporation of arachidonoyl-CoA to produce PAF precursor membrane glycerophospholipids (lysophosphatidylcholine acyltransferase activity). Under resting conditions, the enzyme prefers arachidonoyl-CoA and contributes to membrane biogenesis. Upon acute inflammatory stimulation with lipopolysaccharide, the activated enzyme utilizes acetyl-CoA more efficiently and produces PAF
Products: -
?
additional information
?
-
Substrates: LPCAT2 also possesses lysophosphatidylcholine acyltransferase, EC: 2.3.1.23, activity that catalyzes the incorporation of arachidonoyl-CoA into membrane phosphatidylcholine
Products: -
?
additional information
?
-
-
Substrates: LPCAT2 also possesses lysophosphatidylcholine acyltransferase, EC: 2.3.1.23, activity that catalyzes the incorporation of arachidonoyl-CoA into membrane phosphatidylcholine
Products: -
?
additional information
?
-
Substrates: LPCAT2 also possesses lysophosphatidylcholine acyltransferase, EC: 2.3.1.23, activity that catalyzes the incorporation of arachidonoyl-CoA into membrane phosphatidylcholine
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(-)-epicatechin-3-O-gallate
-
IC50: 0.072 mM
(-)-epigallocatechin
-
IC50: 0.073 mM
(-)-epigallocatechin-3-O-gallate
-
IC50: 0.046 mM
(4,4',5,5',6,6'-hexahydroxybiphenyl-2,2'-diyl)bis[(2R,3R)-5,7-dihydroxy-3,4-dihydro-2H-chromene-2,3-diyl] bis(3,4,5-trihydroxybenzoate)
-
-
1,2,3,4,6-pentagalloyl-beta-D-glucose
-
IC50: 0.026 mM
1,4-diacetoxy-2-methoxy-5-methyl-3-tetradecanoyloxybenzene
-
1-acyl-sn-glycero-3-phosphate
-
competitive inhibition for 1-alkyl-sn-glycero-3-phosphate
1-methoxyphaseolidin
-
IC50: 0.048 mM
1-methoxyphaseolin
-
IC50: 0.057 mM
1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine
-
irreversible inhibition dependent of both 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine and enzyme concentration
1-O-alkyl-sn-glycero-3-phosphocholine
-
inhibition at high concentrations due to its detergent effect
2-methoxy-1,3,4-trihydroxy-5-methylbenzene
i.e. 2-methoxy-1,3,4-trihydroxy-5-methylbenzene, isolated from Penicillium sp. strain F33
2-methoxy-5-methyl-1,3,4-triacetoxybenzene
-
2-methoxy-5-methyl-3-octadecanoyloxy-1,4-benzoquinone
-
2-methoxy-5-methyl-3-tetradecanoyloxy-1,4-benzoquinone
3,4-dichloro-1-(4,5-dichloro-2-methoxyphenyl)-1H-pyrrole-2,5-dione
3,4-dihydroxy-1,2-dimethoxy-5-methylbenzene
-
3-acetoxy-2-methoxy-5-methyl-1,4-benzoquinone
-
3-chloro-1-(3-chloro-4-methoxyphenyl)-4-(2-methoxyphenoxy)-1H-pyrrole-2,5-dione
3-chloro-1-(4,5-dichloro-2-methoxyphenyl)-4-(2-hydroxyanilino)-1H-pyrrole-2,5-dione
3-chloro-4-(morpholin-4-yl)-1-(4-phenoxyphenyl)-1H-pyrrole-2,5-dione
3-decanoyloxy-2-methoxy-5-methyl-1,4-benzoquinone
3-hexanoyloxy-2-methoxy-5-methyl-1,4-benzoquinone
-
3-hydroxy-2-methoxy-5-methyl-1,4-benzoquinone
-
4-(1-Naphthylvinyl)pyridine
-
IC50: 0.043 mM
6,8-diprenylgenistein
-
IC50: 0.019 mM
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
i.e. Trolox, reduces production of platelet-activating factor (PAF) in H2O2-treated HUVEC cells
ascorbic acid
-
18.3% inhibition at 1 mM
butyl 4-(3,4-dichloro-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate
chiyusaponin
-
IC50: 0.2 mM
dexamethasone
-
2 mg/kg for 3 days in liver and spleen
dihydrofumigatin
i.e. 2-methoxy-1,3,4-trihydroxy-5-methylbenzene, isolated from Penicillium sp. strain F33
diisopropylfluorophosphate
ebselen
-
suppresses alkyl-2-acetyl-sn-glycero-3-phosphocholine synthesis by 7.7% and 26.6% in presence of glutathione
farnesyl gallate
-
IC50: 0.066 mM
gallic acid
-
5.3% inhibition at 0.1 mM
geranyl gallate
-
IC50: 0.089 mM
glutathione
-
suppresses alkyl-2-acetyl-sn-glycero-3-phosphocholine synthesis by 18.9%
H2O2
-
8% inhibition at 1 mM
licoricidin
-
IC50: 0.0077 mM
lopinavir-r
-
remaining activity in human mesangial cells: 76%. By contrast no effect on activity is observed in blood of naiive patients treated with the drug
luteolin
-
IC50: 0.045 mM
lysophosphatidylcholine
-
inhibition at high concentrations due to its detergent effect
medroxyprogesterone
-
50 mg/kg in liver
methyl 4-(3,4-dichloro-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate
methyl 4-[3-chloro-2,5-dioxo-4-(4-sulfamoylanilino)-2,5-dihydro-1H-pyrrol-1-yl]benzoate
MgATP2-
-
32% and 54% inhibition at 0.125 and 1 mM respectively in neuronal nuclear fraction
myricetin
-
suppresses alkyl-2-acetyl-sn-glycero-3-phosphocholine synthesis by 17%
N-acetylcysteine
reduces production of platelet-activating factor (PAF) in H2O2-treated HUVEC cells
n-dodecyl gallate
-
IC50: 0.091 mM
nordihydroguaiaretic acid
oleic acid
-
1-acyl lysolipids less inhibited than the 1-alkyl species
p-chloromercuribenzoate
-
-
palmitoyllyso-glycero-3-phosphocholine
phenylmethylsulfonyl fluoride
-
30% inhibition at 50 mM
procyanidin B-2,3,3'-di-O-gallate
-
IC50: 0.031 mM
procyanidin B-5,3,3'-di-O-gallate
-
IC50: 0.024 mM
propan-2-yl 4-(3,4-dichloro-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate
propan-2-yl 4-(3-chloro-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate
propan-2-yl 4-[3-chloro-4-(2-hydroxyanilino)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl]benzoate
propan-2-yl 4-[3-chloro-4-(morpholin-4-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl]benzoate
propyl 4-(3,4-dichloro-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate
pyrrolidinecarbodithioic acid
i.e. PDTC, reduces production of platelet-activating factor (PAF) in H2O2-treated HUVEC cells
resveratrol
-
0.157 microM, results in 50% inhibition in interleukin 1beta effect on catalytic activity
serine/threonine phosphatase
-
diminishes rates of acetylation for 1-alkyl-sn-glycero-3-phosphocholine and 1-acyl-sn-glycero-3-phosphocholine
-
sodium dodecylsulfate
-
inactivation at 0.1%
tenofovir-DF
-
remaining activity in human mesangial cells: 32%. By contrast no effect on activity is observed in blood of naiive patients treated with the drug
theaflavin
-
IC50: 0.032 mM
theaflavin-3'-O-gallate
-
IC50: 0.039 mM
theaflavin-3,3'-di-O-gallate
-
IC50: 0.028 mM
theaflavin-3-O-gallate
-
IC50: 0.058 mM
theasinensin A
-
IC50: 0.029 mM
Triton X-100
-
75 and 95% inhibition at 0.2 and 0.6 mM respectively due to detergent
tyrosol
-
0.048 microM, results in 50% inhibition in interleukin 1beta effect on catalytic activity
Urea
-
inactivation at 8 mM
2-methoxy-5-methyl-3-tetradecanoyloxy-1,4-benzoquinone
derivative of a metabolite from Penicillium sp. F33 , strong inhibition. Compound also significantly suppresses the gene expression of lyso-PAF acetyltransferase/LPCAT2 in mouse bone marrow-derived macrophages stimulated by lipopolysaccharide
2-methoxy-5-methyl-3-tetradecanoyloxy-1,4-benzoquinone
-
derivative of a metabolite from Penicillium sp. F33 , strong inhibition. Compound also significantly suppresses the gene expression of lyso-PAF acetyltransferase/LPCAT2 in mouse bone marrow-derived macrophages stimulated by lipopolysaccharide
3,4-dichloro-1-(4,5-dichloro-2-methoxyphenyl)-1H-pyrrole-2,5-dione
-
3,4-dichloro-1-(4,5-dichloro-2-methoxyphenyl)-1H-pyrrole-2,5-dione
-
3-chloro-1-(3-chloro-4-methoxyphenyl)-4-(2-methoxyphenoxy)-1H-pyrrole-2,5-dione
-
3-chloro-1-(3-chloro-4-methoxyphenyl)-4-(2-methoxyphenoxy)-1H-pyrrole-2,5-dione
-
3-chloro-1-(4,5-dichloro-2-methoxyphenyl)-4-(2-hydroxyanilino)-1H-pyrrole-2,5-dione
-
3-chloro-1-(4,5-dichloro-2-methoxyphenyl)-4-(2-hydroxyanilino)-1H-pyrrole-2,5-dione
-
3-chloro-4-(morpholin-4-yl)-1-(4-phenoxyphenyl)-1H-pyrrole-2,5-dione
-
3-chloro-4-(morpholin-4-yl)-1-(4-phenoxyphenyl)-1H-pyrrole-2,5-dione
-